| Jerome N Kopelman, MD | |
|
419 W Redwood St, Suite 500, Baltimore, MD 21201-1734 | |
| (410) 328-0253 | |
| Not Available |
| Full Name | Jerome N Kopelman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 46 Years |
| Location | 419 W Redwood St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457389728 | NPI | - | NPPES |
| S186 / 0069 | Other | MD | BLUECHOICE |
| LT35 / 748413-05 | Other | MD | BC / BS OF MD |
| 233500000 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center Inc | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Paul Place Specialists Inc | 7719882943 | 268 |
| University Of Maryland Obstetrical And Gynecological Associates Pa | 8820083363 | 30 |
News Archive
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.
Scientists at Johannes Gutenberg University Mainz in Germany have discovered a new signal pathway in the brain that plays an important role in learning and the processing of sensory input. It was already known that distinct glial cells receive information from neurons.
Blood tests that could detect cancer before it develops show promise for the future of screening and prevention, though researchers continue to test which cancer clues are good markers for diagnosis.
› Verified 1 days ago
| Entity Name | St Paul Place Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871549196 PECOS PAC ID: 7719882943 Enrollment ID: O20031202000084 |
News Archive
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.
Scientists at Johannes Gutenberg University Mainz in Germany have discovered a new signal pathway in the brain that plays an important role in learning and the processing of sensory input. It was already known that distinct glial cells receive information from neurons.
Blood tests that could detect cancer before it develops show promise for the future of screening and prevention, though researchers continue to test which cancer clues are good markers for diagnosis.
› Verified 1 days ago
| Entity Name | University Of Maryland Obstetrical And Gynecological Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144252990 PECOS PAC ID: 8820083363 Enrollment ID: O20040415000691 |
News Archive
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.
Scientists at Johannes Gutenberg University Mainz in Germany have discovered a new signal pathway in the brain that plays an important role in learning and the processing of sensory input. It was already known that distinct glial cells receive information from neurons.
Blood tests that could detect cancer before it develops show promise for the future of screening and prevention, though researchers continue to test which cancer clues are good markers for diagnosis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jerome N Kopelman, MD 110 S Paca St, Suite 6n300, Baltimore, MD 21201-1642 Ph: (410) 328-0253 | Jerome N Kopelman, MD 419 W Redwood St, Suite 500, Baltimore, MD 21201-1734 Ph: (410) 328-0253 |
News Archive
NYU School of Medicine's Cosimo Commisso, PhD, a postdoctoral fellow in the Department of Biochemistry, is the 2011 recipient of The Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship, a one-year grant designed to support pancreatic cancer research.
Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.
Scientists at Johannes Gutenberg University Mainz in Germany have discovered a new signal pathway in the brain that plays an important role in learning and the processing of sensory input. It was already known that distinct glial cells receive information from neurons.
Blood tests that could detect cancer before it develops show promise for the future of screening and prevention, though researchers continue to test which cancer clues are good markers for diagnosis.
› Verified 1 days ago
Miss Elizabeth Unique Morris, MSN, WHNP-BC Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 N Howard St, Baltimore, MD 21201 Phone: 410-576-1414 | |
Christine E. O Connor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 227 Saint Paul St, 6th Floor, Baltimore, MD 21202 Phone: 410-332-9002 Fax: 410-783-5880 | |
Fateh Hraky Sr., Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Suite 301, Baltimore, MD 21225 Phone: 410-350-0800 | |
Joyce A Bonsu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3449 Wilkens Ave Ste 305, Baltimore, MD 21229 Phone: 410-644-2582 Fax: 410-644-6232 | |
Fouad M Abbas, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2411 W Belvedere Ave, Suite 206, Baltimore, MD 21215 Phone: 410-601-9030 | |
Dr. Ginny M Merryman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6569 N Charles St, Suite 501, Baltimore, MD 21204 Phone: 410-938-8960 Fax: 410-583-9770 | |
Dr. Golsa Mirmiran Yazdy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave Bldg A1, Baltimore, MD 21224 Phone: 410-550-0337 Fax: 410-550-0196 |